Common medications in this class include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound), though tirzepatide is technically a dual GIP/GLP-1 receptor agonist
What Makes Retatrutide Different
You can quit at any time
Mild flushing or warmth shortly after dosing
The medication may make the journey easier, but it doesnt eliminate the journey itself.
Ensuring precise drug delivery, monitoring efficacy, and minimizing immune response risks are critical for ADC drug development and clinical application